ISLAMABAD: Pakistan has partnered with a leading Swiss pharmaceutical firm, Roche, to provide costly cancer treatment to Pakistani patients free of cost, the country’s health minister said on Friday, as the two sides signed an agreement in this regard.
Cancer is an insidious disease, alarmingly shaping the global health crisis as it claims millions of lives each year. Responsible for one in six deaths worldwide, cancer cases are projected to reach 26 million annually by 2030, with developing countries shouldering 75% of this burden.
Over 70% of cancer deaths occur in low- and middle-income countries (LMICs), where survival rates hover at just 30%. The reasons are manifold, including inadequate access to early detection and treatment services, lack of awareness, and societal taboos, to name a few.
In Pakistan alone, more than 185,000 new cases and more than 125,000 deaths are reported annually. Breast cancer is the most common, accounting for 16.5% of cases, followed by lip and oral cavity cancers (8.6%) and lung cancer (5.1%), according to Aga Khan University Hospital (AKUH).
“Roche Pakistan has proposed to the government many years ago that the cure for this cancer is only with them... and they want to do a partnership with the Government of Pakistan. They want to give 70% of the price of the medicine,”
